Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?

Our data suggest that ICI may be effective for PML treatment but were less impressive than the ones previously reported. Larger studies are thus warranted to confirm this efficacy and to identify the predictive factors of response.